Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions
about
Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction.Development of microcolumn-based one-site immunometric assays for protein biomarkersAnalysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.The bioanalytical challenge of determining unbound concentration and protein binding for drugs.Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.Chromatographic immunoassays: strategies and recent developments in the analysis of drugs and biological agents.Recent developments in emerging microimmunoassays.Use of protein G microcolumns in chromatographic immunoassays: A comparison of competitive binding formatsAnalysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatographyAnalysis of biomolecular interactions using affinity microcolumns: a review.Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling.High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.Polymethacrylate-based monoliths as stationary phases for separation of biopolymers and immobilization of enzymes.Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.Peak decay analysis and biointeraction studies of immunoglobulin binding and dissociation on protein G affinity microcolumns.
P2860
Q33847684-B7787305-BF7C-4D78-BEB4-F5DB3D02502EQ34332587-5DE4E1F2-12D9-40F2-A098-8F024AA65660Q34625180-94735A29-D00C-4875-8638-F39D2BE15B3FQ35062663-3F734019-35F8-48EB-B07B-9F16EF6A773AQ36494517-64E498A1-F802-4533-A27D-B60E8D282411Q36619568-80CC2949-A54C-45FC-8C07-B7FCA9ECDD0EQ36765073-BA5B6DA9-88FA-413A-91A1-566BBC2DC66BQ36851285-C9F48C6E-6EB8-456D-A5AB-8218BA3FC21FQ36889177-B5A10C42-5E6A-41E9-B744-40F2A95F9424Q37267433-857C3BAE-D97F-4126-9F94-941BC60A4631Q38191351-58B0BF4C-96E2-4146-8B0A-A9CED02EB56BQ38861933-5ACA72C2-8837-413D-BFC9-3D2D87BA40ADQ47336088-B6EC9DEF-0EBC-4E4C-AFD7-BAC2F2F30754Q48009897-3CFCA219-B9E7-4D77-B54F-C0E9487D0505Q52365560-5469248C-CD48-4A59-B71B-DAA0ECDEB5E6Q53420236-8C7ADCE6-579E-4B74-A186-B47914E2B7A5
P2860
Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Development of a flow-based ul ...... nalysis of free drug fractions
@ast
Development of a flow-based ul ...... nalysis of free drug fractions
@en
type
label
Development of a flow-based ul ...... nalysis of free drug fractions
@ast
Development of a flow-based ul ...... nalysis of free drug fractions
@en
prefLabel
Development of a flow-based ul ...... nalysis of free drug fractions
@ast
Development of a flow-based ul ...... nalysis of free drug fractions
@en
P2093
P2860
P356
P1433
P1476
Development of a flow-based ul ...... nalysis of free drug fractions
@en
P2093
Chainarong Sakulthaew
David S Hage
John E Schiel
Zenghan Tong
P2860
P304
P356
10.1021/AC201973V
P407
P577
2011-11-28T00:00:00Z